Connect Biopharma Holdings Ltd (CNTB) — Working Capital to Net Assets Ratio
Connect Biopharma Holdings Ltd (CNTB) has a Working Capital to Net Assets ratio of 89.1% as of March 2026. Working capital of $37.98 Million (current assets of $55.02 Million minus current liabilities of $17.05 Million) is measured against net assets of $42.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Connect Biopharma Holdings Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Connect Biopharma Holdings Ltd Working Capital to Net Assets (2018–2025)
This chart shows how Connect Biopharma Holdings Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 89.1%, reflecting working capital of $37.98 Million against net assets of $42.62 Million USD. See CNTB cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Connect Biopharma Holdings Ltd (2018–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Connect Biopharma Holdings Ltd from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CNTB market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.9% | $37.32 Million | $41.98 Million | $50.93 Million | $13.61 Million | ▼ -7.1 pp |
| 2024 | 96.0% | $88.50 Million | $92.17 Million | $96.96 Million | $8.46 Million | ▲ +0.2 pp |
| 2023 | 95.8% | $97.26 Million | $101.50 Million | $122.55 Million | $25.29 Million | ▲ +6.8 pp |
| 2022 | 89.0% | $140.16 Million | $157.49 Million | $155.78 Million | $15.62 Million | ▼ -5.5 pp |
| 2021 | 94.4% | $257.14 Million | $272.26 Million | $275.13 Million | $17.98 Million | ▲ +193.8 pp |
| 2020 | -99.4% | $23.89 Million | $-24.03 Million | $24.78 Million | $890.94K | ▲ +13.0 pp |
| 2019 | -112.4% | $6.95 Million | $-6.18 Million | $7.52 Million | $568.07K | ▲ +233.3 pp |
| 2018 | -345.7% | $67.11 Million | $-19.41 Million | $68.08 Million | $966.56K | — |